Cardanol polyamine derivative modified zeolite composite hemostatic material as well as preparation method and application thereof

Modifying natural zeolites by modifying cashew phenol polyamine derivatives solves the problem of easy water absorption and lack of antibacteriality of zeolite materials, improves the moisture resistance and antibacterial properties of hemostatic materials, reduces the risk of thrombosis, and is suitable for special hemostatic fields.

CN119015474APending Publication Date: 2024-11-26NASURFAR BIOMATERIAL TECH (CHANGSHU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411141942.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing natural zeolite materials are prone to absorb water, resulting in failure of performance, microparticles may cause thrombosis risk during hemostasis, and the lack of antibacterial function leads to wound infection.

Method used

Modified cashew phenol polyamine derivatives interact with the surface of natural zeolites through Mannich reaction, modifying their surfaces to form a zeolite composite hemostatic material modified by cashew phenol polyamine derivatives, reducing the risk of particle peeling and improving moisture resistance and antibacterial properties.

Benefits of technology

It significantly improves the anti-moisture effect of zeolite materials, reduces the risk of micro-nano particles entering the blood, enhances antibacterial function, and is suitable for special hemostasis fields such as military industry.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015474A_ABST
    Figure CN119015474A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of an anacardol polyamine derivative modified zeolite composite hemostatic material. The anacardol polyamine derivative modified zeolite composite hemostatic material is prepared from anacardol polyamine derivative modified natural zeolite. The invention further discloses the composite hemostatic material prepared by the preparation method and application of the composite hemostatic material. The anacardol polyamine derivative modified zeolite hemostatic has the advantages that the hygroscopicity is obviously reduced while the high specific surface area of a zeolite material is maintained, the anti-moisture effect is greatly improved, and the anacardol polyamine derivative modified zeolite hemostatic is expected to be applied to the special hemostatic field of military industry and the like. After the surface of the zeolite is modified with the cardanol polyamine derivative, the stripping performance of the particles is remarkably reduced, and the risk of blockage after the micro-nano zeolite particles enter blood can be effectively reduced. Phenolic hydroxyl groups and amido groups in the cardanol polyamido derivative endow the composite hemostatic material with a good antibacterial function. The cardanol derivative extracted from cashew nut shell oil is used as a raw material, so that the cardanol derivative is simple to prepare, low in cost, green and sustainable, and is beneficial to promoting high-valued and green sustainable development of agricultural and forestry wastes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a zeolite hemostatic material modified by a cardanol polyamine derivative and a preparation method and application thereof, belonging to the technical field of medical materials. Background Art

[0002] In emergency situations such as war, car accidents and other accidents, the body's own hemostatic mechanism cannot effectively supply blood, and uncontrollable traumatic bleeding and infectious complications are the main causes of death. Therefore, timely and effective hemostasis is the key to reducing mortality. Sterilized traditional hemostatic materials, such as cotton wool and gauze, are used for compressive hemostasis at the wound site. They are widely distributed in people's production and life because of their wide range of applications, low prices and convenience. However, traditional hemostatic materials can only play a simple physical protective role on the wound surface, and it is difficult to effectively control the amount of bleeding caused by sudden arterial hemorrhage, especially when trauma patients cannot obtain a sterile environment, which increases the risk of wound infection. In addition, cotton wool and gauze are easy to adhere to the wound, which is relatively cumbersome in the post-processing process and can cause severe pain to the injured. Tourniquets, as another common hemostatic material, achieve hemostasis by compressing blood vessels, but their hemostatic effect is insufficient, and excessive addition of antibiotics in hemostatic materials may also lead to drug resistance problems. In recent years, hemostatic materials have developed rapidly, and new products have emerged in an endless stream, such as cellulose, chitosan, gelatin and other materials. This type of material has the advantages of wide source, low price, high biocompatibility and good adhesion. However, there are a series of problems in hemostatic efficiency, antibacterial, water absorption and swelling, and its application in special fields such as military industry is limited.

[0003] Zeolite is a microporous aluminosilicate mineral with a huge surface area. It also has ultra-high hygroscopicity, low swelling and excellent hemostatic properties. Since its launch, commercial hemostatic drugs based on zeolite have developed rapidly and are inexpensive. The hemostatic effect of its particles has been verified in multiple animal models. The main problems with the application of zeolite materials in the field of hemostasis include: 1. Zeolite has a large specific surface area and strong hygroscopicity. The hemostatic effect decreases significantly after being damp, affecting its application in special hemostatic fields such as military industry. 2. When zeolite comes into contact with blood, particles are prone to peeling, forming micro-nano-scale particles, which are easy to enter blood vessels and cause blockage, causing serious secondary infections. 3. Zeolite itself lacks antibacterial function and needs to be used in combination with antibacterial agents, which increases the complexity of hemostasis.

[0004] Research on improving zeolite hemostatic agents mainly focuses on: 1. Improving hemostatic efficiency. Lisha Yu used a template-free growth route to tightly bond mesoporous single-crystal dolomite zeolite to the surface of cotton fibers. Compared with most other clay or zeolite-based inorganic hemostats, the synthesized hemostatic device has superior hemostatic performance, higher procoagulant activity, minimized loss of active ingredients, and better practical application scalability. 2. Composite with fibers and two-dimensional materials, fix micro-nano particles, and reduce the risk of vascular occlusion. Yuping Liang et al. cross-linked graphene oxide sponge with zeolite-based hemostatic agents, combined the advantages of zeolite and graphene oxide, and used the thermal conductivity and lamellar structure of graphene oxide to eliminate the side effects of wounds, while maintaining the stimulation of blood coagulation, achieving a win-win situation in terms of efficient hemostasis and biosafety; Yang Wang et al. used an in situ growth biosynthesis process to prepare sandwich-structured bacterial cellulose / zeolite hybrid hemostatic agents, realizing a low-cost, environmentally friendly and low-risk method for preparing zeolite-based composite hemostatic materials for pre-hospital hemostasis applications. 3. Add antibacterial agents to zeolite to improve the antibacterial properties of zeolite. Tong Xu et al. developed a zeolite doped with Ag. The in-situ doping of Ag can produce reactive oxygen to kill bacteria and improve inflammation caused by bacteria, which can also be used to promote cell proliferation to accelerate wound healing. Bingqi Zhu et al. added polysaccharide-based composite dressings to zeolite. The results showed that the composite dressing not only has antibacterial activity, but also has a fast wound recovery rate after use. It has shown significant effects in both in vivo and in vitro hemostasis experiments, has good wound healing properties, and can also reduce the thermal effect caused by zeolite during hemostasis. Summary of the invention

[0005] Purpose of the invention: To address the problems of the porous surface of existing natural zeolites, which easily absorb water and lead to material performance failure, the easy generation of microparticles during the hemostasis process, which poses a risk of thrombosis, and the lack of antibacterial function, leading to wound infection, a composite hemostatic material of zeolite modified with a polyamine derivative of cardanol is provided to alleviate the above problems.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is as follows:

[0007] The invention discloses a method for preparing a zeolite composite hemostatic material modified by a cardanol polyamine derivative. The material is prepared by modifying a natural zeolite by a cardanol polyamine derivative.

[0008] The structural schematic diagram of the cardanol polyamine derivative modified zeolite hemostatic material of the present invention is as follows Figure 1 shown.

[0009] Wherein, the cardanol polyamine derivative is obtained by modifying cardanol with a polyamine derivative through the Mannich reaction (for the specific preparation method, refer to Liu Xiaoying, Lin Jinhuo. Study on the synthesis, characterization and properties of amino cardanol [J]. Chemistry and Industry of Forest Products, 2003, 23 (4): 71-74.), which has a polyamine group, a long water-repellent side chain and a phenolic hydroxyl functional group, and interacts with the silicon hydroxyl group on the surface of natural zeolite through hydrogen bonding and chemical bonding, thereby modifying the surface of natural zeolite. The polyamine derivative is hexamethylenediamine, diethylenetriamine, isophoronediamine, maleic acid diamine, spermidine or spermine.

[0010] The natural zeolite is a natural aluminate mineral, and its components include silicon oxide, aluminum oxide, titanium oxide, calcium oxide, magnesium oxide, iron oxide, potassium oxide and sodium oxide, wherein the sum of the mass of silicon oxide and aluminum oxide accounts for 70% to 90% of the total mass of the natural zeolite; the natural zeolite has a micropore diameter of 0.3 to 2.0 nm and a specific surface area of ​​30 to 1000 m 2 / g, pore volume is 0.2~1.0cm 3 / g, and the particle size is 1μm-1mm. The natural zeolite is mainly composed of phosphorus, aluminum, and oxygen elements. Oxygen atoms connect silicon-oxygen tetrahedrons and aluminum-oxygen tetrahedrons together to form a three-dimensional framework, showing a porous crystalline solid.

[0011] Wherein, the composite hemostatic material is prepared by the following steps:

[0012] (1) preparing an ethanol solution of a cardanol polyamine derivative, and subjecting the solution to ultrasonic treatment to obtain a mixture A;

[0013] (2) Mixture A and natural zeolite are thoroughly mixed and heated for reaction.

[0014] In step (1), the cardanol polyamine derivative and anhydrous ethanol are mixed in a mass ratio of 1:4 to 40, the ultrasonic frequency is 40 kHz, and the ultrasonic time is 30 to 60 min.

[0015] In step (2), the mass ratio of the mixture A to the natural zeolite is 1:2-20; the sufficient mixing method includes mixing, grinding, ball milling or direct dropwise addition; the heating reaction has a reaction temperature of 60-100° C. and a total reaction time of 1-3 h.

[0016] Among them, the mixing is stirring and mixing; the grinding is grinding the natural zeolite into small solid particles, and then stirring and mixing with the mixture A; the ball milling is crushing the natural zeolite by impact, extrusion, and friction, and then stirring and mixing with the mixture A; the direct dripping is dripping the mixture A on the surface of the natural zeolite in small amounts multiple times (for example, 1 to 10 drops of the mixture A can be dripped), and heating the reaction for 5 to 8 minutes after each dripping (and the total heating reaction time after multiple dripping is controlled to be 1 to 3 hours), until the mixture A is completely dripped onto the surface of the zeolite particles.

[0017] Cardanol is a non-edible, low-cost, sustainable and widely sourced natural phenolic compound extracted from cashew nut shell liquid. It has a rigid structure similar to a benzene ring, active unsaturated bonds, low viscosity and low volatility. The phenolic hydroxyl group contained in its molecular structure has excellent antibacterial properties; long C 15 The alkane side chain gives it excellent water-repellent properties; the high activity of the ortho-hydrogen of the phenolic hydroxyl group gives it excellent functional group adjustability. After the cardanol polyamine derivatives modify the natural zeolite, the cardanol polyamine derivatives with polyamine groups, phenolic hydroxyl groups, positive charges and cross-linking activity can interact with the aluminum hydroxyl and silicon hydroxyl groups on the surface of the zeolite through hydrogen bonds, electrostatic effects and chemical bonding, which significantly reduces the exfoliation performance of the natural zeolite particles and reduces the risk of blockage of micro-nano zeolite particles entering the blood; the long carbon chain of the cardanol polyamine derivatives enhances the moisture resistance of the natural zeolite; the phenolic hydroxyl and amine groups of the cardanol polyamine derivatives improve the antibacterial properties of the natural zeolite in the process of hemostasis.

[0018] Based on the above advantages, this patent combines cardanol polyamine derivatives with natural zeolite to synergistically solve the application problems of traditional zeolite hemostatic materials in practical applications, especially in special hemostatic fields such as military industry. The beneficial effects of the present invention are:

[0019] 1. The zeolite hemostatic agent modified with cardanol polyamine derivatives significantly reduces the hygroscopicity while maintaining the high specific surface area of ​​the zeolite material, and the moisture resistance effect is greatly improved. It is expected to be used in special hemostatic fields such as military industry.

[0020] 2. After the zeolite surface is modified with cardanol polyamine derivatives, the particle exfoliation performance is significantly reduced, which can effectively reduce the risk of blockage after the micro-nano zeolite particles enter the blood.

[0021] 3. The phenolic hydroxyl and amine groups in the cardanol polyamine derivatives give the composite hemostatic material good antibacterial function.

[0022] 4. The use of cardanol derivatives extracted from cashew nut shell liquid as raw materials is simple to manufacture, low in cost, green and sustainable, and helps promote the high value of agricultural and forestry waste and green and sustainable development. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, and the above and other advantages of the present invention will become more clear.

[0024] Figure 1 The schematic diagram is a structural diagram of a zeolite hemostatic material modified by a cardanol polyamine derivative;

[0025] Figure 2 The infrared spectra of the natural zeolite of Comparative Example 1, the cardanol polyamine derivative of the present invention, and the zeolite hemostatic material modified with different mass fractions of the cardanol polyamine derivative in Examples 1 to 3;

[0026] Figure 3 The water loss specific gravity diagram of the zeolite hemostatic material modified with different mass fractions of the cardanol polyamine derivatives in Examples 1 to 3 and the natural zeolite in Comparative Example 1;

[0027] Figure 4 Thermogravimetric diagrams of zeolite hemostatic materials modified with different mass fractions of cardanol polyamine derivatives in Examples 1 to 3 and natural zeolite in Comparative Example 1;

[0028] Figure 5 The antibacterial effect diagram of the cardanol polyamine derivative modified zeolite hemostatic material in Example 3 and the natural zeolite in Comparative Example 1, the samples in centrifuge tubes ① and ② are the natural zeolite in Comparative Example 1 and the cardanol polyamine derivative modified zeolite hemostatic material in Example 3, respectively, and no material is added to centrifuge tube ③, which serves as a control group;

[0029] Figure 6 This is a comparison chart of the turbidity of water after soaking in deionized water for the natural zeolite in Comparative Example 1 and the zeolite hemostatic material modified with different mass fractions of cardanol polyamine derivatives in Examples 1 to 3. The materials added to the beaker are, from left to right, the natural zeolite in Comparative Example 1, the zeolite hemostatic material modified with cardanol polyamine derivatives in Example 1, the zeolite hemostatic material modified with cardanol polyamine derivatives in Example 2, and the zeolite hemostatic material modified with cardanol polyamine derivatives in Example 3. DETAILED DESCRIPTION

[0030] The present invention is further described below based on the following examples. It should be understood that the following embodiments are only used to illustrate the present invention, but not to limit the present invention.

[0031] The cardanol polyamino derivatives used in the following examples are prepared by the Mannich reaction of hexamethylenediamine with the active hydrogen at the phenolic hydroxyl group of cardanol (for the specific preparation method, refer to Liu Xiaoying, Lin Jinhuo. Study on the synthesis, characterization and properties of aminocardanol [J]. Chemistry and Industry of Forest Products, 2003, 23 (4): 71-74.).

[0032] The natural zeolite was purchased from Hangzhou Feichuang Life Science Co., Ltd. The natural zeolite was measured by XRF analysis to have a composition of silicon oxide (73.519%), aluminum oxide (16.094%), titanium oxide (0.206%), calcium oxide (2.579%), magnesium oxide (0.353%), iron oxide (1.039%), potassium oxide (1.677%) and sodium oxide (4.299%) and other trace components (the content of each component is less than 0.1%); the natural zeolite was measured by BET to have a micropore diameter of 1.5 nm and a specific surface area of ​​70 m 2 / g, pore volume is 0.5cm 3 / g, and the average particle size is 200μm.

[0033] Escherichia coli BL21 (DE3) was purchased from Biotech Co., Ltd.

[0034] Example 1

[0035] Accurately weigh 0.1 g of cardanol polyamine derivative and 4 g of anhydrous ethanol using an analytical balance. Ultrasonic treatment at 40 kHz for 30 min allows the cardanol polyamine derivative and anhydrous ethanol to be fully mixed into a solution to obtain a mixture A1;

[0036] Accurately weigh 2 g of natural zeolite particles in a culture dish, add a few drops of mixture A1 drop by drop on the surface of the natural zeolite particles, put it in an oven at 60°C, heat and react for 5 to 8 minutes (make sure the surface of the zeolite is completely dry), continue to add a small amount of mixture A1, put it in an oven at 60°C, heat and react for 5 to 8 minutes, repeat the above steps until all the mixture A1 is added to the surface of the zeolite particles, and store the obtained mixture B1 (the total heating time is controlled at 1 to 3 hours).

[0037] Example 2

[0038] Accurately weigh 0.5 g of cardanol polyamine derivative and 4 g of anhydrous ethanol using an analytical balance. Ultrasonic treatment at 40 kHz for 50 min allows the cardanol polyamine derivative and anhydrous ethanol to be fully mixed into a solution to obtain a mixture A2;

[0039] Accurately weigh 2 g of natural zeolite particles in a culture dish, add a few drops of mixture A2 on the surface of the zeolite particles, put it in an oven at 70°C, and heat it for 5 to 8 minutes (make sure the surface of the zeolite is completely dry), then continue to add a small amount of mixture A2, put it in an oven at 70°C, and heat it for 5 to 8 minutes. Repeat the above steps until all the mixture A2 is added to the surface of the zeolite particles, and store the resulting mixture B2 (the total heating time is controlled at 1 to 3 hours).

[0040] Example 3

[0041] 1 g of cardanol polyamine derivative and 4 g of anhydrous ethanol were accurately weighed using an analytical balance. The cardanol polyamine derivative and anhydrous ethanol were thoroughly mixed into a solution by ultrasonic treatment at 40 kHz for 60 min to obtain a mixture A3;

[0042] Accurately weigh 2 g of natural zeolite particles, put them into a mortar and grind them thoroughly, then pour them into a culture dish. Pour the mixture A3 into the culture dish containing the zeolite particles and mix them directly. Put it into an oven at 90°C and heat it for reaction for 1 to 3 hours, then store the resulting mixture B3.

[0043] Comparative Example 1

[0044] Natural zeolite granules 2g.

[0045] The composite hemostatic material samples obtained in Examples 1 to 3 and the natural zeolite particles in Comparative Example 1 were tested for infrared, moisture resistance, antibacterial properties and zeolite particle peeling performance. The specific testing methods are as follows:

[0046] The different composite hemostatic material samples prepared above were dried in an oven at 60° C. for 24 hours to obtain the samples to be tested.

[0047] Figure 2 It is the infrared spectra of the zeolite hemostatic material modified with different mass fractions of the cardanol polyamine derivatives and the natural zeolite in Example 1, Example 2, Example 3 and Comparative Example 1. Among them, a is the infrared spectrum of natural zeolite; b is the infrared spectrum of the cardanol polyamine derivatives described in the present invention; c is the infrared spectrum of the zeolite hemostatic material modified with the cardanol polyamine derivatives of Example 1; d is the infrared spectrum of the zeolite hemostatic material modified with the cardanol polyamine derivatives of Example 2; e is the infrared spectrum of the zeolite hemostatic material modified with the cardanol polyamine derivatives of Example 3. FTIR spectrum further confirms the hydrogen bonding effect between the cardanol polyamine derivatives and the zeolite molecules. As can be seen from the figure, the infrared spectra c, d, and e at 2885cm -1 The characteristic peaks of methyl and methylene in cardanol polyamine derivatives appeared at all locations, and the peak signals increased with the increase in the amount of cardanol polyamine derivatives.

[0048] Figure 3 The zeolite hemostatic materials modified with different mass fractions of cardanol polyamine derivatives in Example 1, Example 2, Example 3 and Comparative Example 1 and the natural zeolite are respectively swollen by water, and the weight is weighed after swelling equilibrium and recorded as W1. Then, the materials are placed in a thermostatic oven at 80°C, and the weight W is measured every 5 to 30 minutes. T The water loss specific gravity of natural zeolite and zeolite modified with cardanol polyamine derivatives at time T is the mass W of the sample at time T. TThe ratio of the mass W1 of the swelling equilibrium. As can be seen from the figure, the zeolite compounded with the cardanol polyamine derivative loses more water than the natural zeolite and loses water faster. With the increase of the cardanol content, the moisture resistance effect is improved to a certain extent, indicating that the compounding of the cardanol polyamine derivative improves the moisture resistance of the zeolite raw material.

[0049] Figure 4 The thermogravimetric graphs of the zeolite hemostatic materials modified with different mass fractions of cardanol polyamine derivatives and natural zeolite in Example 1, Example 2, Example 3 and Comparative Example 1. After high temperature, the cardanol polyamine derivatives in the cardanol polyamine derivative composite zeolite were thermally decomposed and the weight decreased, proving that the cardanol polyamine derivatives were successfully modified on the zeolite surface.

[0050] Figure 5 The antibacterial effect diagram of the cardanol polyamine derivative modified zeolite hemostatic material in Example 3 and the natural zeolite in Comparative Example 1. Take 3 sterile 10mL centrifuge tubes, numbered as ①, ② and ③. After adding 2mL of sterile LB liquid culture medium to each of the three centrifuge tubes, add 1% (v / v) of common Escherichia coli BL21 (DE3) cultured for 6 hours. Take 0.3g of each sample of Comparative Example 1 and Example 3 and add them to centrifuge tubes ① and ② respectively, and do not add any material to centrifuge tube ③ (control). Put the three centrifuge tubes into a 37℃ shaker, culture at 200r / min for 12h, and observe the growth of bacteria in the liquid culture medium. If there is no bacterial growth, it proves that the material has antibacterial properties. If there is bacterial growth, the bacterial OD can be compared with the control group to determine its antibacterial properties. The antibacterial experiment of each material was repeated 3 times. As can be seen from the figure, the solution in ② is clearer than that in ① and ③, and the OD value of sample ② is 0.3, while the OD values ​​of samples ① and ③ are 0.7 and 0.8 respectively, indicating that the growth of Escherichia coli in sample ② is significantly inhibited, proving that the zeolite composite material modified with cardanol polyamine derivatives has a significant antibacterial effect.

[0051] Figure 6 The following is a comparison of the turbidity of the natural zeolite in Comparative Example 1 and the zeolite hemostatic materials modified with different mass fractions of cardanol polyamine derivatives in Examples 1 to 3 after being soaked in deionized water. Weigh 0.5g of each of the above materials in a beaker filled with 20mL of deionized water and soak at room temperature for 6h. Figure 6As shown, the materials added to the beaker are, from left to right, the natural zeolite in Comparative Example 1, the zeolite hemostatic material modified by the cashew phenol polyamine derivatives in Example 1, the zeolite hemostatic material modified by the cashew phenol polyamine derivatives in Example 2, and the zeolite hemostatic material modified by the cashew phenol polyamine derivatives in Example 3. It can be seen from the figure that the aqueous solution of the natural zeolite in Comparative Example 1 is turbid after immersion, while the aqueous solution of the zeolite hemostatic material modified by the cashew phenol polyamine derivatives with different mass fractions in Example 1, Example 2 and Example 3 has greatly reduced turbidity compared with the natural zeolite aqueous solution, which proves that after the zeolite is modified by the cashew phenol polyamine derivatives, the phenomenon of the zeolite decomposing into small particles when encountering water is significantly suppressed, and the exfoliation performance of the zeolite particles is significantly reduced, which can effectively reduce the risk of blockage of the micro-nano zeolite particles after entering the blood.

[0052] In summary, compared with natural zeolite, the zeolite hemostatic material modified by cardanol polyamine derivatives improves the moisture resistance and stability of the hemostatic material at the molecular scale, reduces the risk of vascular occlusion, and significantly improves the antibacterial property.

[0053] The present invention provides a method and idea for the preparation and application of a zeolite composite hemostatic material modified by a cardanol polyamine derivative. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention. All components not specified in this embodiment can be implemented using existing technologies.

Claims

1. A method for preparing a zeolite composite hemostatic material modified with a cardanol polyamine derivative, characterized in that: It is prepared by modifying natural zeolite with cardanol polyamine derivatives.

2. The preparation method according to claim 1, characterized in that: The cardanol polyamine derivative is prepared by modifying cardanol with a polyamine derivative through a Mannich reaction.

3. The preparation method according to claim 2, characterized in that: The polyamine derivative is hexamethylenediamine, diethylenetriamine, isophoronediamine, maleic acid diamine, spermidine or spermine.

4. The preparation method according to claim 1, characterized in that: The natural zeolite comprises silicon oxide, aluminum oxide, titanium oxide, calcium oxide, magnesium oxide, iron oxide, potassium oxide and sodium oxide, wherein the sum of the mass of silicon oxide and aluminum oxide accounts for 70% to 90% of the total mass of the natural zeolite; the natural zeolite has a micropore diameter of 0.3 to 2.0 nm and a specific surface area of ​​30 to 1000 m 2 / g, pore volume is 0.2~1.0cm 3 / g, and the particle size is 1μm~1mm.

5. The preparation method according to claim 1, characterized in that: The composite hemostatic material is prepared by the following steps: (1) preparing an ethanol solution of a cardanol polyamine derivative, and subjecting the solution to ultrasonic treatment to obtain a mixture A; (2) Mixture A and natural zeolite are thoroughly mixed and heated for reaction.

6. The preparation method according to claim 5, characterized in that: In step (1), the cardanol polyamine derivative and anhydrous ethanol are mixed in a mass ratio of 1:4 to 40, the ultrasonic frequency is 40 kHz, and the ultrasonic time is 30 to 60 min.

7. The preparation method according to claim 5, characterized in that: In step (2), the mass ratio of the cardanol polyamine derivative to the natural zeolite is 1:2-20; the sufficient mixing method includes mixing, grinding, ball milling or direct dropwise addition; the heating reaction has a reaction temperature of 60-100° C. and a total reaction time of 1-3 h.

8. The preparation method according to claim 7, characterized in that: The mixing is stirring and mixing; the grinding is grinding the natural zeolite into small solid particles, and then stirring and mixing with the mixture A; the ball milling is crushing the natural zeolite by impact, extrusion, and friction, and then stirring and mixing with the mixture A; the direct dripping is dripping the mixture A on the surface of the natural zeolite in small amounts and multiple times, heating and reacting for 5 to 8 minutes after each dripping, until the mixture A is completely dripped onto the surface of the zeolite particles.

9. The composite hemostatic material prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the composite hemostatic material according to claim 9 in the preparation of hemostatic materials.